MetLife (MET) Receives Extension to Resubmit Capital Plan
Tweet Send to a FriendGet Alerts MET Hot Sheet
Price: $45.41 +1.14%
Overall Analyst Rating:
BUY (
Down)
Dividend Yield: 2.7%
Revenue Growth %: +1.7%
Overall Analyst Rating:
BUY (
Down)Dividend Yield: 2.7%
Revenue Growth %: +1.7%
Trade MET Now!
According to a Form 8-K, MetLife (NYSE: MET) has received an extension to resubmit its capital plan. The company will now have until September 30th.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Rambus (RMBS) Enters License with STMicro (STM)
- NVIDIA (NVDA) Changes Business Model; Plans to License GPU Technology
- FT Fed Writer Tells Market to 'Chill Out' on Fed Tapering Nervousness
Create E-mail Alert Related Categories
Corporate News, Fed
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
